Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
MAIA Biotechnology, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 8-K Quarterly results
08/24/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "MAIA Biotechnology Reports Second Quarter 2023 Financial Results and Provides Updates for THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer"
07/18/2023 RW Form RW - Registration Withdrawal Request:
07/11/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
07/11/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"MAIA Biotechnology Reports Updates on Disease Control Rates for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer"
07/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "MAIA Biotechnology Reports Updates on Preliminary Survival Data for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer"
06/30/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/09/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
06/08/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Quarterly results
Docs: "MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update"
04/27/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Underwriting Agreement by and between the Company and the Representative",
"MAIA Biotechnology, Inc. Announces Pricing of Public Offering",
"MAIA Biotechnology, Inc. Announces Closing of Public Offering"
04/27/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/25/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/21/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/20/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
04/20/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/20/2023 8-K Quarterly results
04/19/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/18/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
04/18/2023 8-K Quarterly results
04/04/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
03/24/2023 10-K Annual Report for the period ended December 31, 2022
03/24/2023 8-K Quarterly results
Docs: "MAIA Biotechnology Reports Full Year 2022 Financial Results and Provides Corporate Update"
03/17/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/14/2023 SC 13G Louie Ngar Yee reports a 9.6% stake in §240.13d-2 MAIA BIOTECHNOLOGY, INC.
02/14/2023 SC 13G Gryaznov Sergei reports a 7.7% stake in §240.13d-2 MAIA BIOTECHNOLOGY, INC.
02/14/2023 SC 13G Vitoc Vlad reports a 24% stake in §240.13d-2 MAIA BIOTECHNOLOGY, INC.
02/13/2023 8-K/A Quarterly results
02/13/2023 8-K Quarterly results
02/13/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
02/06/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy